查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1862524

产时监护设备市场按技术、应用、最终用户、设备类型和分销管道划分－2025-2032年全球预测

Intrapartum Monitoring Devices Market by Technology, Application, End User, Device Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，产时监护设备市场规模将达到 31.8 亿美元，复合年增长率为 6.94%。

关键市场统计数据
基准年 2024 18.5亿美元
预计年份：2025年 19.8亿美元
预测年份 2032 31.8亿美元
复合年增长率 (%) 6.94%

确定推动产时监测设备创新、改善母婴结果并提高工作流程效率的紧迫临床和技术要务。

产时监护设备是母胎临床护理与不断发展的医疗技术之间至关重要的桥樑。这些设备旨在产程中持续或间断地监测胎心率和子宫活动，其双重目标是在最大限度改善新生儿预后的同时，最大限度地减少不必要的干预。近年来，该领域的生态系统已从传统的有线系统发展到模组化、无线、软体驱动的平台，这些平台更加重视提高数据准确性、临床医生工作流程效率和患者移动性。

感测器创新、无线连接和数据驱动的临床智慧在重塑产时护理连续体中的监测模式和商业策略方面发挥着重要作用

产时监护设备领域正经历着变革性的转变，从核心感测技术到护理服务的操作模式都发生了翻天覆地的变化。无线遥测、新一代感测器和先进讯号处理技术的突破，使得在传统产房之外也能进行持续、高精度的监护。同时，软体技术的进步也为这些发展提供了有力支撑，这些软体运用模式识别和预测分析技术处理胎儿和子宫数据，从而为临床医生提供更早、更准确的潜在问题预警。

了解2025年关税变化如何推动医疗设备价值链的供应链多元化、采购调整和长期製造策略转变。

2025年美国关税调整为产时监护设备的製造商、经销商和医疗采购商带来了新的动态。直接的营运影响包括重新评估关键零件（例如专用感测器、印刷基板组件和无线模组）的供应链配置。为此，一些製造商正在加快供应商多元化，增加关键零件的库存缓衝，并考虑将部分组件的生产转移到近岸地区，以降低关税波动带来的风险。

将技术选择、临床应用、终端用户环境、设备类别和分销模式等多维度细分洞察转化为可执行的产品策略。

将产时监护市场从技术、应用、终端用户、设备类型和通路等多个维度进行整合分析，可以更细緻地观点影响产品需求和购买行为的因素。从技术面来看，产时监护可分为外部监护和内部监护。外部监测包括胎心监测（CTG）和多普勒超音波，而内部监测包括胎儿头皮电极和子宫内压力导管。这些技术差异导致临床上需要在非侵入性操作的便利性和内部感测器提供的讯号精确度之间做出权衡，从而影响急诊和非急诊护理环境中的采购偏好。

区域市场动态和采购行为（美洲、欧洲、中东和非洲、亚太地区）将决定产品采用路径和商业化方式。

区域趋势对产时监护生态系中的技术应用、采购惯例和商业策略产生了显着影响。在美洲，对数位医疗基础设施的投资、成熟的医院系统以及对基于价值的医疗结果的高度重视，正在推动对能够改善临床工作流程和互通性的整合监护解决方案的需求。采购者往往倾向于选择那些提供全面服务协议、临床培训以及能够证明其对医疗成本产生影响的供应商，而这反过来又决定了供应商如何优先考虑认证和支援服务。

在产时监测设备市场，竞争优势是透过检验的临床平台、综合服务产品以及能够提升设备价值的策略伙伴关係建立起来的。

产时监护领域的竞争格局并非取决于单一功能差异，而是取决于产品系列的广度、临床验证和服务生态系统。领先的製造商通常会将硬体平台与专有的讯号处理技术和使用者介面软体结合，打造整合解决方案，从而减轻临床医生的认知负荷，并增强其决策信心。同时，一群新兴的数位医疗公司正在提供进阶分析、云端连接和远距监护服务，以补充传统的设备产品。

製造商和供应商面临的实际策略挑战是，如何利用模组化、互联平台来增强供应链韧性、检验临床价值并获得长期应用。

产业领导者应采取果断措施，使产品开发、供应链韧性和市场进入策略与不断变化的临床和商业性预期保持一致。首先，应实现供应链多元化，减少对单一供应商的依赖，并投资于零件标准化，以实现替代采购，同时最大限度地减少重新认证。这种方法有助于在贸易政策变化的情况下保持产品连续性，并为医疗系统客户提供更可预测的服务。

透明、多维度的调查方法：整合临床医生访谈、监管和供应链分析以及迭代检验，以确保获得可靠且可操作的见解。

本分析的调查方法整合了多种证据来源和检验步骤，以确保其严谨性和相关性。主要研究包括对不同医疗机构的产科医生、采购人员、医疗设备工程师和分销合作伙伴进行结构化访谈，以收集他们对器械性能、易用性和采购因素的本地化观点。此外，还对监管申报文件、临床指南和同行评审文献进行了系统性回顾，以提供文献证据支持技术和临床方面的论点。

从全面视角探讨如何将技术进步、监管变革和供应链韧性转化为产时护理中可衡量的临床和营运改进

产时监护设备处于临床需求与快速技术创新的交汇点，为改善产妇结局和服务创新创造了重要机会。不断演变的医疗模式、日益严格的监管要求以及供应链重组等多重压力，正迫使製造商提供经临床检验、互通性且具有可靠性的解决方案。从临床角度来看，无线和软体增强型监护技术的进步有望将高品质监护的范围扩展到传统产房之外，同时保持讯号保真度和临床操作便利性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 即时人工智慧预测分析用于分娩过程中胎儿窘迫的检测
  • 无线穿戴式母婴监护贴片可在家庭环境中持续评估分娩进展。
  • 透过整合远端医疗平台和产时监测设备实现虚拟产程管理
  • 利用先进的感测器融合技术进行非侵入性子宫活动监测，可提高宫缩检测的准确性。
  • 为新兴的、资源有限的医疗保健市场开发低成本、便携式产时监护系统
  • 一种新型薄膜电化学胎儿心电图电极可减少讯号干扰并提高监测清晰度。
  • 云端基础的医疗物联网（IoMT）解决方案整合了交付数据，以实现即时临床决策支援仪表板。
  • 以患者为中心的行动应用程式（整合分娩过程中母亲的回馈和来自产时监测设备的关键数据）
  • 采用生物相容性涂层的微创胎儿头皮监测导管可降低高风险分娩期间的感染风险
  • 以超音波和子宫收缩测量相结合的混合头盆监测技术进行分娩期全面评估的准确性

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按技术分類的围产期监测设备市场

  • 外部监测
    • 胎儿心音图
    • 超音波
  • 内部监控
    • 胎儿头皮电极
    • 子宫内压力导管

第九章 按应用分類的产时监护设备市场

  • 持续监测
    • 固定係统
    • 无线系统
  • 间歇性监测
    • 携带式多普勒
    • 携带式显示器

第十章 依最终用户分類的围产期监测设备市场

  • 门诊手术中心
  • 居家医疗
  • 医院
    • 私立医院
    • 公立医院
  • 妇产科中心

第十一章 依设备类型分類的围产期监测设备市场

  • 劳动监测装置
    • 外部宫缩压力计
    • 子宫内压力导管
  • 胎儿监视器
    • 胎心率和产程监测
    • 多普勒胎儿分娩监视器
    • 胎儿心电图监视器

第十二章 按分销管道分類的产时监护设备市场

  • 医院采购
  • 线上销售
  • 零售
  • 第三方经销商

第十三章 围产期监测设备市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 产时监护设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国产时监护设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • General Electric Company
    • Koninklijke Philips NV
    • Baxter International Inc.
    • Dragerwerk AG & Co. KGaA
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Medtronic plc
    • NIHON KOHDEN CORPORATION
    • Natus Medical Incorporated
    • Edan Instruments, Inc.
    • Huntleigh Healthcare Limited
Product Code: MRR-521BAA36EB40

The Intrapartum Monitoring Devices Market is projected to grow by USD 3.18 billion at a CAGR of 6.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.85 billion
Estimated Year [2025] USD 1.98 billion
Forecast Year [2032] USD 3.18 billion
CAGR (%) 6.94%

Framing the urgent clinical and technological imperatives driving innovation in labor monitoring systems to enhance maternal and neonatal outcomes while improving workflow efficiency

Intrapartum monitoring devices occupy a critical nexus between maternal-fetal clinical care and advancing medical technology. These devices are designed to continuously or intermittently observe fetal heart rate and uterine activity during labor, with the dual objectives of maximizing neonatal outcomes and minimizing unnecessary interventions. Over recent years, the ecosystem has evolved from legacy wired systems toward modular, wireless, and software-enabled platforms that emphasize data fidelity, clinician workflow efficiency, and improved patient mobility.

Clinical stakeholders seek devices that deliver clear, actionable signals while integrating seamlessly with electronic health record systems and delivery room workflows. At the same time, clinicians and procurement leaders demand evidence of clinical validity, ease of use, and robust infection control processes. As a result, manufacturers are balancing engineering innovation with human factors design and regulatory rigor to meet the needs of obstetric teams in varied care settings.

Transitioning from hospital-centric monitoring to hybrid care models that include ambulatory surgical centers and home healthcare settings has placed new requirements on device portability, wireless reliability, and remote monitoring capabilities. Consequently, the sector is witnessing parallel advances in sensing hardware, signal processing algorithms, and connectivity architectures. Taken together, these trends underscore a field that is both clinically indispensable and technically dynamic, creating an imperative for stakeholders to align product development, clinical validation, and go-to-market strategies around measurable improvements in safety and workflow.

How sensor innovation, wireless connectivity, and data-driven clinical intelligence are reshaping monitoring paradigms and commercial strategies across the intrapartum care continuum

The intrapartum monitoring landscape is undergoing transformative shifts that extend from core sensing technologies to the operational models of care delivery. Technological breakthroughs in wireless telemetry, next-generation sensors, and advanced signal processing are enabling continuous, high-fidelity monitoring outside the confines of the traditional delivery suite. These developments are complemented by software advances that apply pattern recognition and predictive analytics to fetal and uterine data, offering clinicians earlier and more precise alerts of potential compromise.

Simultaneously, care delivery is being reconfigured by the growth of decentralized models: fixed monitoring systems remain central to tertiary hospitals, while wireless and portable solutions enable monitoring in ambulatory surgical centers, maternity centers, and home settings. Payers and health systems emphasizing value-based care are prioritizing devices that demonstrate reductions in avoidable interventions and improved throughput. In regulatory terms, authorities are increasingly focused on software quality, cybersecurity, and interoperability standards, compelling vendors to incorporate compliance by design.

Market participants are also reshaping commercial strategies through collaborations between traditional medical device manufacturers and digital health companies to combine hardware reliability with cloud-native analytics. As a result, product roadmaps are prioritizing user-centered interfaces, secure data transmission, and clinical validation pathways that prove real-world utility. In short, the convergence of sensor innovation, connectivity, and data science is redefining what intrapartum monitoring can deliver for clinicians and expectant families.

Understanding how 2025 tariff revisions are catalyzing supply chain diversification, procurement adjustments, and longer term manufacturing strategy shifts in the medical device value chain

The 2025 tariff adjustments in the United States have introduced a new set of dynamics for manufacturers, distributors, and healthcare purchasers of intrapartum monitoring devices. The immediate operational effect has been a reassessment of supply chain configurations for critical components such as specialized sensors, printed circuit assemblies, and wireless modules. In response, several manufacturers have accelerated diversification of supplier bases, increased inventory buffers for key parts, and evaluated nearshoring for subassemblies to reduce exposure to tariff volatility.

These supply chain responses have downstream implications for procurement cycles and contract negotiations. Hospitals and maternity centers are placing greater emphasis on supplier resilience and transparent cost breakdowns during tendering. Meanwhile, distributors are renegotiating terms with suppliers to preserve service levels, and logistics partners are adapting routing to mitigate customs-related delays. Over time, these adaptations influence product roadmaps by shifting component selection toward parts with more stable sourcing profiles and by encouraging modular designs that can accept alternative supplier inputs with minimal requalification overhead.

Finally, the policy environment has catalyzed conversations about domestic manufacturing incentives, which some manufacturers view as an opportunity to align regulatory, quality, and procurement advantages. While relocation and retooling require capital and regulatory revalidation, the longer-term strategic benefit may include shortened lead times, reduced tariff exposure, and stronger relationships with domestic health systems that prioritize locally produced medical technologies. In essence, tariffs have prompted a strategic reassessment across the value chain that favors resilience, flexibility, and supplier transparency.

Interpreting multidimensional segmentation insights that connect technology choices, clinical applications, end-user environments, device categories, and distribution models into actionable product strategies

A nuanced view of the intrapartum monitoring market emerges when the landscape is structured by technology, application, end user, device type, and distribution pathways as integrated dimensions that shape product requirements and buyer behavior. From a technology perspective, the market is studied across external monitoring and internal monitoring; external approaches encompass cardiotocography and Doppler ultrasonography while internal approaches include fetal scalp electrodes and intrauterine pressure catheters. These technological distinctions create differing clinical trade-offs between noninvasive ease-of-use and the signal fidelity afforded by internal sensors, which in turn inform procurement preferences in high-acuity versus lower-acuity settings.

When analyzed by application, the market is studied across continuous monitoring and intermittent monitoring. Continuous monitoring displays a bifurcation between fixed systems that anchor delivery suite monitoring and wireless systems that enable mobility and remote oversight. Intermittent monitoring includes handheld Doppler devices and portable monitors that support routine checks and community-based care. The choice between continuous and intermittent approaches reflects clinical protocols, staff availability, and the care setting's tolerance for investment in infrastructure.

Examining end users clarifies deployment patterns across ambulatory surgical centers, home healthcare providers, hospitals, and maternity centers; within hospitals, distinctions between private and public institutions influence procurement cycles, budgetary constraints, and service expectations. Device type further refines product positioning as the market is studied across contraction monitoring devices and fetal monitoring devices. Contraction monitoring is differentiated into external tocodynamometers and intrauterine pressure catheters, while fetal monitoring encompasses cardiotocography monitors, Doppler fetal monitors, and fetal ECG monitors, each offering distinct trade-offs in fidelity, invasiveness, and clinical applicability.

Lastly, distribution channel dynamics-spanning hospital purchase, online sales, retail sales, and third-party distributors-shape availability, post-sale service expectations, and pricing strategies. Integrated manufacturers with direct hospital relationships often emphasize installation and training, whereas online and retail channels prioritize ease of ordering and rapid delivery. Taken together, these segmentation lenses reveal that successful offerings must be engineered and marketed in ways that reflect the interplay of clinical requirements, procurement complexity, and distribution realities.

Regional market dynamics and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and commercialization approaches

Regional dynamics exert a strong influence on technology adoption, procurement practices, and commercial strategy across the intrapartum monitoring ecosystem. In the Americas, investment in digital health infrastructure, mature hospital systems, and a strong emphasis on value-based outcomes drive demand for integrated monitoring solutions that can demonstrate improved clinical workflows and interoperability. Procurement tends to favor vendors that provide comprehensive service agreements, clinical training, and evidence of cost-of-care impact, which informs how suppliers prioritize certifications and support offerings.

In Europe, the Middle East, and Africa, regulatory harmonization across parts of Europe is balanced by heterogeneous procurement norms and budget constraints in many markets. Public healthcare purchasers often emphasize total cost of ownership and long procurement cycles, whereas private maternity centers may pursue differentiated technology to attract patients. Across the region, data privacy and cybersecurity requirements shape product development priorities, and multinational suppliers must tailor compliance approaches to local regulatory frameworks.

The Asia-Pacific region is characterized by rapid adoption in urban centers, a strong supplier and manufacturing presence, and an expanding private healthcare sector that demands both advanced technologies and cost-effective models. Rural and peri-urban care settings in several markets present opportunities for portable and low-power devices that enable decentralized monitoring. As a result, product strategies that include tiered features, localized technical support, and supply chain partnerships are especially effective in driving adoption across diverse geographies. Across all regions, cross-border trade dynamics and regulatory alignment play decisive roles in how companies deploy resources and prioritize market entry.

How competitive advantage in the intrapartum monitoring market is built through validated clinical platforms, integrated service offerings, and strategic partnerships that extend device value

Competitive dynamics in intrapartum monitoring are shaped less by single-feature differentiation and more by portfolio breadth, clinical validation, and service ecosystems. Leading manufacturers often combine hardware platforms with proprietary signal processing and user interface software to create integrated solutions that reduce clinician cognitive load and enhance decision confidence. Meanwhile, an emerging cohort of digital health firms contributes advanced analytics, cloud connectivity, and remote monitoring services that complement traditional device offerings.

Companies are increasingly pursuing hybrid commercial models that mix direct hospital sales with channel partnerships, online ordering, and distributor networks to address varied procurement preferences. In parallel, investment in clinical evidence generation-through observational studies, randomized trials, and real-world evidence collection-has become a central competitive lever, providing the foundation for guideline inclusion and payer conversations. Aftermarket services such as training programs, preventive maintenance, and device-as-a-service options are differentiators that strengthen customer retention and create recurring revenue streams.

Finally, strategic alliances between device manufacturers and health systems, software vendors, or contract manufacturers are accelerating time-to-market and expanding capability stacks. These alliances enable faster regulatory pathways for combined hardware-software propositions, allow access to complementary sales channels, and support the scaling of remote monitoring services. Collectively, these company-level approaches emphasize the importance of clinical validation, service excellence, and ecosystem partnerships in sustaining competitive advantage.

Practical strategic imperatives for manufacturers and suppliers to bolster supply resilience, validate clinical value, and leverage modular, connected platforms to win long-term adoption

Industry leaders should take decisive steps to align product development, supply chain resilience, and market access strategies with evolving clinical and commercial expectations. First, diversify supply chains to reduce single-source exposure and invest in component standardization to enable alternative sourcing without extensive requalification. This approach preserves product continuity in the face of trade policy shifts and supports more predictable service commitments to health system customers.

Second, prioritize investments in wireless connectivity, cybersecurity, and cloud-enabled analytics to support remote monitoring and telehealth workflows. These capabilities must be paired with rigorous clinical validation and transparent performance metrics to earn clinician trust. Third, design modular product architectures that allow incremental upgrades in software and sensing capabilities; modularity reduces upgrade costs for customers and accelerates the deployment of new analytical features.

Fourth, engage proactively with payers and health system procurement teams to build reimbursement narratives grounded in clinical outcomes and operational efficiency. Demonstrable reductions in unnecessary interventions, improved throughput, and better patient experience will be central to those conversations. Fifth, expand service offerings to include training, preventative maintenance, and outcome-driven support contracts that align vendor incentives with clinical success. Finally, accelerate partnerships with digital health firms, academic centers, and local manufacturing partners to combine clinical credibility, analytic capability, and supply chain flexibility. These strategic moves create a durable foundation for growth and resilience in a shifting policy and clinical environment.

A transparent, multi-method research framework combining clinician interviews, regulatory and supply chain analysis, and iterative validation to ensure robust actionable insights

The research methodology underpinning this analysis integrates multiple evidence streams and validation steps to ensure rigor and relevance. Primary research included structured interviews with obstetric clinicians, procurement leaders, biomedical engineers, and distribution partners across varied healthcare settings to capture frontline perspectives on device performance, usability, and procurement drivers. These qualitative inputs were complemented by systematic reviews of regulatory filings, clinical guidelines, and peer-reviewed literature to ground technological and clinical claims in documented evidence.

To map supply chain dynamics and tariff impacts, the methodology incorporated supplier mapping exercises, trade flow analyses, and input from logistics specialists to identify points of vulnerability and common mitigation strategies. Data triangulation techniques were employed to reconcile divergent inputs and validate assumptions. In addition, scenario testing and sensitivity analyses were used to examine how changes in procurement preferences, care models, and policy shifts could alter strategic priorities for stakeholders.

Quality assurance included cross-validation workshops with external clinical advisors and technical reviewers, as well as iterative checks for internal consistency and traceability to source data. Limitations and uncertainties were explicitly documented, and where evidence gaps existed, the analysis identified high-priority areas for further primary study. Overall, the methodology emphasizes transparency, multi-stakeholder validation, and a balance between technical detail and strategic applicability.

Concluding perspectives on translating technological advances, regulatory changes, and supply resilience into measurable clinical and operational improvements in intrapartum care

Intrapartum monitoring devices stand at the intersection of clinical necessity and rapid technological change, creating significant opportunities for improved outcomes and service innovation. The combined pressures of evolving care models, heightened regulatory expectations, and supply chain realignment are pushing manufacturers to deliver solutions that are clinically validated, interoperable, and resilient. From a clinical perspective, the move toward wireless, software-enhanced monitoring offers the potential to extend high-quality oversight beyond the traditional delivery room while preserving signal fidelity and clinician usability.

Commercially, companies that integrate hardware reliability with advanced analytics, flexible service models, and demonstrated outcome improvements will be best positioned to succeed. Procurement stakeholders will increasingly reward transparent supply chains, strong post-sale support, and clear evidence of impact on care pathways. As stakeholders adapt to policy changes and shifting care delivery models, collaboration across clinical, technical, and commercial domains will be essential. Ultimately, the path forward requires a disciplined focus on clinical evidence, system interoperability, and supply chain adaptability to translate technological promise into measurable improvements in maternal and neonatal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Real-time AI-powered predictive analytics for fetal distress detection during labor
  • 5.2. Wireless wearable maternal and fetal monitoring patch enabling continuous labor assessment in home settings
  • 5.3. Integration of remote telehealth platforms with intrapartum monitoring devices for virtual labor management
  • 5.4. Non-invasive uterine activity monitoring using advanced sensor fusion for enhanced contraction detection accuracy
  • 5.5. Development of low-cost portable intrapartum monitoring systems for resource-limited and emerging healthcare markets
  • 5.6. Novel thin-film electrochemical fetal ECG electrodes reducing signal interference and improving monitoring clarity
  • 5.7. Cloud-based Internet of Medical Things solutions aggregating labor data for real-time clinical decision support dashboards
  • 5.8. Patient-centric mobile applications integrating maternal feedback and biometric data from intrapartum monitoring devices
  • 5.9. Minimally invasive fetal scalp monitoring catheters with biocompatible coatings reducing infection risk during high-risk deliveries
  • 5.10. Hybrid cephalopelvic monitoring combining ultrasound and tocodynamometry for comprehensive intrapartum assessment accuracy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intrapartum Monitoring Devices Market, by Technology

  • 8.1. External Monitoring
    • 8.1.1. Cardiotocography
    • 8.1.2. Doppler Ultrasonography
  • 8.2. Internal Monitoring
    • 8.2.1. Fetal Scalp Electrode
    • 8.2.2. Intrauterine Pressure Catheter

9. Intrapartum Monitoring Devices Market, by Application

  • 9.1. Continuous Monitoring
    • 9.1.1. Fixed Systems
    • 9.1.2. Wireless Systems
  • 9.2. Intermittent Monitoring
    • 9.2.1. Handheld Doppler
    • 9.2.2. Portable Monitors

10. Intrapartum Monitoring Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
    • 10.3.1. Private Hospital
    • 10.3.2. Public Hospital
  • 10.4. Maternity Centers

11. Intrapartum Monitoring Devices Market, by Device Type

  • 11.1. Contraction Monitoring Device
    • 11.1.1. External Tocodynamometer
    • 11.1.2. Intrauterine Pressure Catheter
  • 11.2. Fetal Monitoring Device
    • 11.2.1. Cardiotocography Monitors
    • 11.2.2. Doppler Fetal Monitors
    • 11.2.3. Fetal ECG Monitors

12. Intrapartum Monitoring Devices Market, by Distribution Channel

  • 12.1. Hospital Purchase
  • 12.2. Online Sales
  • 12.3. Retail Sales
  • 12.4. Third-Party Distributors

13. Intrapartum Monitoring Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intrapartum Monitoring Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intrapartum Monitoring Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. General Electric Company
    • 16.3.2. Koninklijke Philips N.V.
    • 16.3.3. Baxter International Inc.
    • 16.3.4. Dragerwerk AG & Co. KGaA
    • 16.3.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 16.3.6. Medtronic plc
    • 16.3.7. NIHON KOHDEN CORPORATION
    • 16.3.8. Natus Medical Incorporated
    • 16.3.9. Edan Instruments, Inc.
    • 16.3.10. Huntleigh Healthcare Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INTRAPARTUM MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INTRAPARTUM MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAPARTUM MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTIO